Status:
UNKNOWN
Survival Outcomes of Uterine Malignancies in Chinese Population
Lead Sponsor:
Lei Li
Conditions:
Endometrial Neoplasms
Survival
Eligibility:
FEMALE
Brief Summary
This study aims to determine survival outcomes (overall survival and progression-free survival) of primary uterine malignancies in China and relevant risk factors in a prospective cohort study.
Eligibility Criteria
Inclusion
- Primary uterine malignancies.
Exclusion
- Metastatic malignancies to uterine corpus
Key Trial Info
Start Date :
September 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT03291275
Start Date
September 1 2017
End Date
September 1 2023
Last Update
February 8 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lei Li
Beijing, China/Beiing, China, 100000